Jessica Elizabeth Stewart Shay, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypoxia-Inducible Factor 1, alpha Subunit | 5 | 2018 | 627 | 0.910 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2023 | 161 | 0.790 |
Why?
|
| Gastroesophageal Reflux | 1 | 2023 | 782 | 0.540 |
Why?
|
| Alcoholism | 2 | 2023 | 1906 | 0.540 |
Why?
|
| Liver Transplantation | 2 | 2023 | 2118 | 0.490 |
Why?
|
| Gastrointestinal Diseases | 1 | 2023 | 1169 | 0.490 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2018 | 1114 | 0.400 |
Why?
|
| Cell Hypoxia | 4 | 2018 | 675 | 0.340 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 2 | 2015 | 38 | 0.250 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 2942 | 0.200 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2022 | 93 | 0.200 |
Why?
|
| Hypertension, Portal | 1 | 2022 | 220 | 0.180 |
Why?
|
| Serum Amyloid A Protein | 1 | 2018 | 121 | 0.160 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2019 | 194 | 0.160 |
Why?
|
| Ascites | 1 | 2019 | 344 | 0.150 |
Why?
|
| Intestinal Diseases | 1 | 2022 | 531 | 0.150 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2022 | 388 | 0.150 |
Why?
|
| Acriflavine | 1 | 2014 | 6 | 0.120 |
Why?
|
| Hypoxia-Inducible Factor 1 | 2 | 2012 | 198 | 0.120 |
Why?
|
| End Stage Liver Disease | 1 | 2018 | 314 | 0.120 |
Why?
|
| Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 2013 | 8 | 0.120 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 6773 | 0.120 |
Why?
|
| Minoxidil | 1 | 2013 | 33 | 0.110 |
Why?
|
| Inflammation | 1 | 2012 | 10634 | 0.100 |
Why?
|
| Macrophages | 2 | 2018 | 5657 | 0.100 |
Why?
|
| Citrates | 1 | 2011 | 131 | 0.100 |
Why?
|
| Ketoglutaric Acids | 1 | 2011 | 78 | 0.100 |
Why?
|
| Alcohol Drinking | 1 | 2023 | 3966 | 0.090 |
Why?
|
| Colitis | 1 | 2018 | 1170 | 0.090 |
Why?
|
| Tumor Burden | 1 | 2014 | 1914 | 0.080 |
Why?
|
| Neoplasms | 3 | 2012 | 21672 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2014 | 10480 | 0.070 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2011 | 871 | 0.070 |
Why?
|
| Neutrophils | 1 | 2018 | 3717 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2014 | 3557 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 2015 | 2069 | 0.070 |
Why?
|
| Heart Diseases | 1 | 2018 | 2790 | 0.060 |
Why?
|
| Collagen | 1 | 2013 | 2689 | 0.060 |
Why?
|
| Stress, Physiological | 1 | 2012 | 1404 | 0.060 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 2636 | 0.060 |
Why?
|
| Tumor Microenvironment | 2 | 2012 | 3584 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 4841 | 0.050 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2015 | 3385 | 0.050 |
Why?
|
| Zambia | 1 | 2022 | 261 | 0.050 |
Why?
|
| Sarcoma | 1 | 2013 | 1897 | 0.050 |
Why?
|
| Baclofen | 1 | 2022 | 129 | 0.050 |
Why?
|
| Obesity | 1 | 2023 | 12742 | 0.050 |
Why?
|
| Oxygen | 1 | 2012 | 4187 | 0.050 |
Why?
|
| Peritoneovenous Shunt | 1 | 2019 | 9 | 0.050 |
Why?
|
| Humans | 12 | 2023 | 744220 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 16687 | 0.040 |
Why?
|
| Naltrexone | 1 | 2022 | 307 | 0.040 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2019 | 40 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2023 | 77426 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 7723 | 0.040 |
Why?
|
| Ascitic Fluid | 1 | 2019 | 192 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 18027 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2022 | 1184 | 0.040 |
Why?
|
| Fetal Proteins | 1 | 2018 | 94 | 0.040 |
Why?
|
| Animals | 6 | 2018 | 168788 | 0.040 |
Why?
|
| South Africa | 1 | 2022 | 1731 | 0.040 |
Why?
|
| Disease Progression | 1 | 2014 | 13280 | 0.040 |
Why?
|
| Serum Albumin | 1 | 2019 | 676 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2018 | 15294 | 0.030 |
Why?
|
| HIV Infections | 1 | 2022 | 16718 | 0.030 |
Why?
|
| Mice | 4 | 2018 | 81178 | 0.030 |
Why?
|
| Sarcoma, Experimental | 1 | 2013 | 128 | 0.030 |
Why?
|
| Cell Survival | 2 | 2015 | 5881 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 1086 | 0.030 |
Why?
|
| Hydrocephalus | 1 | 2019 | 748 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2022 | 1864 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2018 | 14556 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 1836 | 0.030 |
Why?
|
| Carboxylic Acids | 1 | 2011 | 99 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2022 | 3036 | 0.020 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2011 | 361 | 0.020 |
Why?
|
| Citric Acid Cycle | 1 | 2011 | 232 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2014 | 23404 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 13668 | 0.020 |
Why?
|
| Colon | 1 | 2018 | 1772 | 0.020 |
Why?
|
| Oxidative Phosphorylation | 1 | 2012 | 480 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 21824 | 0.020 |
Why?
|
| Glutamine | 1 | 2011 | 578 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2011 | 1682 | 0.020 |
Why?
|
| Female | 4 | 2022 | 380197 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 2187 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 1869 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 6313 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2018 | 5021 | 0.020 |
Why?
|
| Incidence | 1 | 2022 | 20945 | 0.010 |
Why?
|
| RNA Interference | 1 | 2011 | 2890 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 2727 | 0.010 |
Why?
|
| Cell Movement | 1 | 2013 | 5216 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 25043 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 9735 | 0.010 |
Why?
|
| Glucose | 1 | 2011 | 4396 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2015 | 11478 | 0.010 |
Why?
|
| Adult | 2 | 2022 | 214035 | 0.010 |
Why?
|
| Time Factors | 1 | 2018 | 40063 | 0.010 |
Why?
|
| Middle Aged | 2 | 2022 | 213367 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2018 | 40559 | 0.010 |
Why?
|
| Child | 1 | 2022 | 77679 | 0.010 |
Why?
|
| Male | 2 | 2022 | 350027 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 163253 | 0.000 |
Why?
|